TBC1D22A Antikörper

Produktnummer ABIN7131302

Dieser Kaninchen Polyklonal Antikörper erkennt spezifisch TBC1D22A in ELISA und IHC. Er zeigt eine Reaktivität gegenüber Human.

Kurzübersicht für TBC1D22A Antikörper (ABIN7131302)

Target: TBC1D22A (TBC1 Domain Family, Member 22A (TBC1D22A))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser TBC1D22A Antikörper ist unkonjugiert

Applikation: ELISA, Immunohistochemistry (IHC)

Produktdetails anti-TBC1D22A Antikörper

Verwendungszweck: TBC1D22A Antibody

Kreuzreaktivität: Maus

Aufreinigung: Antigen affinity purification

Immunogen: Fusion protein of Human TBC1D22A

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer:  pH 7.4 PBS, 0.05 % Sodium azide, 40 % Glycerol

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu TBC1D22A

Target: TBC1D22A (TBC1 Domain Family, Member 22A (TBC1D22A))

Andere Bezeichnung: TBC1D22A

Hintergrund:

Background: TBC1D22A (TBC1 domain family, member 22A), also known as C22orf4, is a 517 amino acid protein that contains one Rab-GAP TBC domain and is thought to function as a GTPase-activating protein for Rab family members. Multiple isoforms of TBC1D22A exist due to alternative splicing events. The gene encoding TBC1D22A maps to human chromosome 22, which houses over 500 genes and is the second smallest human chromosome. Mutations in several of the genes that map to chromosome 22 are involved in the development of Phelan-McDermid syndrome, neurofibromatosis type 2, autism and schizophrenia. Additionally, translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia chromosome and the subsequent production of the novel fusion protein BCR-Abl, a potent cell proliferation activator found in several types of leukemias.

Aliases: TBC1D22A antibody, C22orf4 antibody, TBC1 domain family member 22A antibody

UniProt: Q8WUA7